EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrating Multi-Omics and Machine Learning to Reveal a Prognostic Model for Prostate Cancer Metastatic Recurrence Associated with Epithelial–Mesenchymal Transition Features

Xueqian Zhang, Wei Zhang, Zheng Wang, Xinyang Shi, Chenghao Zhang, Yan Gao, Yiheng Deng, Tianyu Shen, Ziyan An iD, Weijun Fu

Genes · 2026

DOI: 10.3390/genes17091015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2026. Verfasst von Xueqian Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Epithelial-Mesenchymal Transition, Machine Learning, Biomarkers, Tumor. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Beijing Natural Science Foundation, National Natural Science Foundation of China, Beijing Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prostate cancer (PCa) is a leading cause of cancer-related mortality worldwide, highlighting the need for improved prognostic tools. The integration of artificial intelligence (AI) and machine learning (ML) with multi-omics data offers new opportunities for biomarker discovery and risk stratification.

Methods

We integrated bulk transcriptomic data from GSE116918 (training, n = 248) and three cross-cohort consistency evaluation cohorts (TCGA-PRAD, GSE70769, GSE46602), focusing on 1087 epithelial–mesenchymal transition (EMT)-associated genes. Using consensus clustering, weighted gene co-expression network analysis (WGCNA), and 91 machine learning algorithm combinations (including Random Forest, Lasso, and CoxBoost), we constructed a prognostic signature. SHAP analysis was used for model interpretability. Single-cell RNA sequencing (scRNA-seq, GSE268307, 10,672 cells) and spatial transcriptomics (10× Genomics Visium FFPE) provided hypothesis-generating evidence; spatial analysis was based on one tissue section.

Results

A three-gene signature (INHBA, FAP, ITGBL1) effectively stratified patients into high- and low-risk groups, with the high-risk group showing significantly worse metastasis-free survival (HR = 1.61, 95% CI: 1.39–1.87; 4-year AUC = 0.93 in the training cohort; external AUCs ranged from 0.62 to 0.77). CytoTRACE inferred high differentiation potential of COMP+ fibroblasts, and Monocle3 inferred a transcriptional transition from COMP+ toward NELL2+ fibroblasts. BayesPrism deconvolution suggested that high inferred COMP+ fibroblast abundance was associated with poor prognosis and advanced T stage. NicheNet analysis prioritized BMP7 as a key upstream ligand, with downstream targets enriched in TGF-β signaling and stem cell pluripotency pathways.

Conclusions

This study presents a machine learning-based multi-omics framework for prostate cancer risk stratification. The three-gene signature provides a new exploratory prognostic model while inferring a COMP+ to NELL2+ transcriptional transition. These findings may inform future hypothesis-driven studies of treatment sensitivity, pending experimental validation, and demonstrate the value of AI-driven multi-omics integration for precision oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsEpithelial-Mesenchymal TransitionMachine LearningBiomarkers, TumorNeoplasm Recurrence, LocalHumansMalePrognosisMultiomicsGene Expression Regulation, NeoplasticTranscriptomeNeoplasm MetastasisGene Expression Profiling

Stichwörter der Autor:innen

epithelial–mesenchymal transitionmachine learningmulti-omics analysisprostate cancertumor microenvironment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • School of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, China.
  • Department of Urology, PLA General Hospital, Beijing 100039, China.
  • School of Medical Technology, Hebei Medical University, Shijiazhuang 050031, China.
  • Department of Urology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.

ORCID-Profile: Ziyan An

Förderung

  • the Beijing Natural Science Foundation
  • National Natural Science Foundation of China
  • Beijing Natural Science Foundation

Zitieren

APA

Zhang, X., Zhang, W., Wang, Z., Shi, X., Zhang, C., Gao, Y., Deng, Y., Shen, T., An, Z., & Fu, W. (2026). Integrating Multi-Omics and Machine Learning to Reveal a Prognostic Model for Prostate Cancer Metastatic Recurrence Associated with Epithelial–Mesenchymal Transition Features. Genes. https://doi.org/10.3390/genes17091015

Vancouver

Zhang X, Zhang W, Wang Z, Shi X, Zhang C, Gao Y, et al. Integrating Multi-Omics and Machine Learning to Reveal a Prognostic Model for Prostate Cancer Metastatic Recurrence Associated with Epithelial–Mesenchymal Transition Features. Genes. 2026. doi:10.3390/genes17091015

BibTeX
@article{Zhang2026,
  author = {Zhang, Xueqian and Zhang, Wei and Wang, Zheng and Shi, Xinyang and Zhang, Chenghao and Gao, Yan and Deng, Yiheng and Shen, Tianyu and An, Ziyan and Fu, Weijun},
  title = {Integrating Multi-Omics and Machine Learning to Reveal a Prognostic Model for Prostate Cancer Metastatic Recurrence Associated with Epithelial–Mesenchymal Transition Features},
  journal = {Genes},
  year = {2026},
  doi = {10.3390/genes17091015}
}
Kostenlos starten →